Skip Navigation

Recommendation Angiogenesis in First Line Advanced NSCLC: Focus on Avastin (Bevacizumab)

Updated Jan 6, 2010, filed in All Journey Phases, Lung Cancer
Video presentation describing the concept behind angiogenesis and the evidence on the anti-angiogenic agent avastin (bevacizumab) in NSCLC.